Katherina Aguilera

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Lab-ansvarig Biomedicinsk analytiker på Kliniskt forskningscentrum Lab, KIDS.

Artiklar

Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1346749
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Bladh O; Aguilera K; Marking U; Kihlgren M; Norin NG; Smed-Sorensen A; Chen MS; Klingstrom J; Blom K; Russell MW; Havervall S; Thalin C; Aberg M
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):72-80
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Manberg A; Marking U; Lauren I; Gabrielsson L; Salomonsson A-C; Aguilera K; Kihlgren M; Mansson M; Rosell A; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Aberg M; Hedhammar M; Tegel H; Donnes P; Phillipson M; Nilsson P; Klingstrom J; Mangsbo S; Hober S; Thalin C
Journal article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):E384
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 (vol 41, pg 988, 2021)
Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thalin C; Phillipson M
Journal article: THROMBOSIS RESEARCH. 2021;200:s77
PO-105 Quantification of citrullinated histones in human blood samples: challenges and development of a nucleosome-based assay to quantify H3Cit-DNA in human plasma
Thålin A; Aguilera K; Hall NW; Marunde MR; Burg JM; Rosell A; Daleskog M; Hisada Y; Meiners MJ; Sun ZW; Whelihan MF; Cheek MA; Howard SA; Saxena-Beem S; Noubouossie DF; Key NS; Sheikh SZ; Keogh MC; Cowles MW; Lundström S; Mackman N; Wallén H; Johnstone AL
Journal article: THROMBOSIS RESEARCH. 2021;200:s32
PO-28 Circulating markers of neutrophil activation and nets, but not of coagulation and fibrinolysis, predict mortality in patients with terminal cancer
Rosell A; Aguilera K; Daleskog M; Hisada Y; Mackman N; Lundström S; Wallén H; Thålin C
Journal article: THROMBOSIS RESEARCH. 2021;200:s79-s80
PO-110 Identification of novel biomarkers to aid in the detection of occult cancer in high-risk patient populations: the BIT and MEDECA studies
Thålin C; Rosell A; Gabrielsson L; Månsson M; Aguilera K; Lundström S; Söderberg M; Hjalmar V; Wallén H; Group FTBAMS
Article: SCIENTIFIC REPORTS. 2021;11(1):5074
Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer
Rosell A; Aguilera K; Hisada Y; Schmedes C; Mackman N; Wallen H; Lundstrom S; Thalin C
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):878-882
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report
Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thalin C
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):988-994
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19
Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thalin C; Phillipson M
Article: NATURE COMMUNICATIONS. 2020;11(1):5064
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg A-S; Havervall S; Manberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson A-C; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellstrom C; Bayati S; Bergstrom S; Pin E; Sjoberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thalin C
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2732-2743
Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma
Thalin C; Aguilera K; Hall NW; Marunde MR; Burg JM; Rosell A; Daleskog M; Mansson M; Hisada Y; Meiners MJ; Sun Z-W; Whelihan MF; Cheek MA; Howard SA; Saxena-Beem S; Noubouossie DF; Key NS; Sheikh SZ; Keogh M-C; Cowles MW; Lundstrom S; Mackman N; Wallen H; Johnstone AL

Alla övriga publikationer

Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2024;38:100872
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
Aguilera K; Bladh O; Marking U; Norin NG; Rihani A; Ujvari D; Ning FC; Klingstroem J; Havervall S; Aberg M; Blom K; Alm JJ; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2024;24(2):e80-e81
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
Preprint: BIORXIV. 2023
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
Marking U; Bladh O; Aguilera K; Yang Y; Norin NG; Blom K; Hober S; Klingström J; Havervall S; Åberg M; Sheward D; Thålin C
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2023;389(17):1626-1628
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection
Bladh O; Greilert-Norin N; Havervall S; Marking U; Aguilera K; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET MICROBE. 2023;4(7):e488
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Bladh O; Marking U; Havervall S; Norin NG; Aguilera K; Hober S; Smed-Soerensen A; Gordon M; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(2):150-152
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Marking U; Bladh O; Havervall S; Svensson J; Greilert-Norin N; Aguilera K; Kihlgren M; Salomonsson A-C; Mansson M; Gallini R; Kriegholm C; Bacchus P; Hober S; Gordon M; Blom K; Smed-Sorensen A; Aberg M; Klingstrom J; Thalin C
Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):e381-e382
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"
Mackman N; Hisada Y; Grover SP; Rosell A; Havervall S; von Meijenfeldt F; Aguilera K; Lisman T; Thalin C
Conference publication: THROMBOSIS RESEARCH. 2021;200:S79-S80
Identification of novel biomarkers to aid in the detection of occult cancer in high-risk patient populations: the BIT and MEDECA studies
Thalin C; Rosell A; Gabrielsson L; Mansson M; Aguilera K; Lundstrom S; Soderberg M; Hjalmar V; Wallen H
Conference publication: THROMBOSIS RESEARCH. 2021;200:S32
Circulating markers of neutrophil activation and nets, but not of coagulation and fibrinolysis, predict mortality in patients with terminal cancer
Rosell A; Aguilera K; Daleskog M; Hisada Y; Mackman N; Lundstrom S; Wallen H; Thalin C
Conference publication: THROMBOSIS RESEARCH. 2021;200:S77
Quantification of citrullinated histones in human blood samples: challenges and development of a nucleosome-based assay to quantify H3Cit-DNA in human plasma
Thalin C; Aguilera K; Hall NW; Marunde MR; Burg JM; Rosell A; Daleskog M; Hisada Y; Meiners MJ; Sun ZW; Whelihan MF; Cheek MA; Howard SA; Saxena-Beem S; Noubouossie DF; Key NS; Sheikh SZ; Keogh MC; Cowles MW; Lundstrom S; Mackman N; Wallen H; Johnstone AL
Preprint: MEDRXIV. 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
Rudberg A-S; Havervall S; Månberg A; Falk AJ; Aguilera K; Ng H; Gabrielsson L; Salomonsson A-C; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellström C; Bayati S; Bergström S; Pin E; Sjöberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thålin C
Preprint: BIORXIV.
Neutralisation sensitivity of the SARS-CoV-2 BA.2.87.1 variant
Sheward DJ; Marking U; Bladh O; Held S; Looyens E; Vandenabeele L; Muschiol S; Aguilera K; Norin NG; Öling S; Westerberg M; Martin D; Hedestam GBK; Albert J; Thålin C; Murrell B

Anställningar

Doktorand, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2024-2027

Examina och utbildning

Biomedicinsk Analytikerexamen, Karolinska Institutet, 2011

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI